Severe SARS-CoV-2 patients develop a higher specific T-cell response.
Demaret J, Lefèvre G, Vuotto F, Trauet J, Duhamel A, Labreuche J, Varlet P, Dendooven A, Stabler S, Gachet B, Bauer J, Prevost B, Bocket L, Alidjinou EK, Lambert M, Yelnik C, Meresse B, Dubuquoy L, Launay D, Dubucquoi S, Montaigne D, Woitrain E, Maggiotto F, Bou Saleh M, Top I, Elsermans V, Jeanpierre E, Dupont A, Susen S, Brousseau T, Poissy J, Faure K, Labalette M; Lille Covid Research Network (LICORNE).
Demaret J, et al. Among authors: dupont a.
Clin Transl Immunology. 2020 Dec 23;9(12):e1217. doi: 10.1002/cti2.1217. eCollection 2020.
Clin Transl Immunology. 2020.
PMID: 33376594
Free PMC article.
OBJECTIVES: Assessment of the adaptive immune response against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is crucial for studying long-term immunity and vaccine strategies. We quantified IFNgamma-secreting T cells reactive against the main viral SARS-CoV- …
OBJECTIVES: Assessment of the adaptive immune response against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is crucial for s …